Clinical Trials · NCT02049866
Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Elizabeth Shane
- Enrollment
- 33
- Start date
- Nov 2014
- Locations
- 2 sites, United States
- Primary endpoint
- Percent Change in Lumbar Spine Areal BMD by DXA